Founded in August 2022, Moonlight AI is specialising in haematology & cytology. Aiming for a market launch in 2024-25, Moonlight AI's genomic biomarker and diagnosis solutions promise to revolutionize cancer diagnostics by addressing significant gaps in molecular testing for accurate patient care.